Adoptive immunotherapy for pancreatic cancer, using MUC-1 specific CTL

Japanese Journal of Cancer and Chemotherapy

Volumn 23, Issue 12, 1996, Pages 1679-1680

  Masaki, Y ^a   Oka, M ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adoptive immunotherapy; MUC1; Pancreatic cancer

Indexed keywords

CYTOTOXIC AGENT; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY MUC 1; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; OKT 8; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; LYMPHOKINE ACTIVATED KILLER CELL; PANCREAS CANCER; PROGNOSIS;

CA-15-3 ANTIGEN; CANCER VACCINES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; PANCREATIC NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029799028     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)